Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Aug;81(2):e89-e90.
doi: 10.1016/j.jinf.2020.05.023. Epub 2020 May 14.

Corticosteroid use in selected patients with severe acute respiratory distress syndrome related to COVID-19

Affiliations
Comment

Corticosteroid use in selected patients with severe acute respiratory distress syndrome related to COVID-19

Suzanne Goursaud et al. J Infect. 2020 Aug.
No abstract available

Keywords: Acute respiratory distress syndrome; COVID-19; Corticosteroids.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest The authors declare that they have no competing interest.

Figures

Fig 1
Fig. 1
(a) Schematic time course of two critically ill COVID-19 patients. Dots and lozenges represent computed tomography and chest X-rays, respectively, corresponding to Fig. 1b. (b) Radiological evolution of two patients with severe acute respiratory distress syndrome related to COVID-19 who were treated with low-dose corticosteroids. ICU: intensive care unit, ECMO: extracorporeal membrane oxygenation.

Comment on

Similar articles

Cited by

References

    1. Yang Z., Liu J., Zhou Y., Zhao X., Zhao Q., Liu J. The effect of corticosteroid treatment on patients with coronavirus infection: a systematic review and meta-analysis. J Infect. 2020 Apr 10 doi: 10.1016/j.jinf.2020.03.062. pii: S0163-4453(20)30191-2[Epub ahead of print] Review. PubMed PMID 32283144. - DOI - PMC - PubMed
    1. Phua J., Weng L., Ling L., Egi M., Lim C.M., Divatia J.V. Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations. Lancet Respir Med. 2020 PMID: 32272080Review. - PMC - PubMed
    1. Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497–506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24. - DOI - PMC - PubMed
    1. World Health Organization. Clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV) infection is suspected—Interim guidance. Published January 28, 2020. Accessed February 11, 2020. https://www.who.int/publications-detail/clinicalmanagement-of-severe-acu...
    1. Russel C.D., Millar J.E., Baillie J.K. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Lancet. 2020;395:473–475. - PMC - PubMed

Substances